ARCHIVES

FDA Expands Gleevec Indication For Children with Ph+ ALL

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Toxic Substance Act Would Affect Cancer Program

March 21, 1975

In Brief: Grants To Get Biggest Share Of NCI’s Extra $74 Million; A PR Failure In Pittsburgh

March 19, 1976

NIH Limits Increases In Competing Renewals To Biomedical Deflator

August 30, 1991

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

October 28, 2005

Group Sets Prostate Research Agenda; Strategy, Funding Demands to Follow

November 8, 1996

In Brief: House, Senate Differ On NCI Positions; Upton Says Viral Oncology research Will Be Continued

August 12, 1977